$TRDA

1 thesis
bullish 0%neutral 0%bearish 100%
Avg return (3m)
Win rate (3m)
(0 resolved)

Past performance does not predict future results. Informational only, not investment advice.

Recent theses

Prices delayed ~15 min · refreshed just now
$TRDASEC Form 4bearish
PARMAR KUSH · Entrada Therapeutics, Inc. · 17h agono track record yet
Sold 155,255 @ $6.95 avg · $1,078,937 · 2026-08-06

Form 4: PARMAR KUSH sold TRDA

PARMAR KUSH (Director at Entrada Therapeutics, Inc.) reported an open-market sale of 155,255 shares of TRDA at an average $6.95, roughly $1,078,937, in a Form 4 filed 2026-08-10.

Now $7.26just now
1d
3d
1w
1m
3m
6m
1y
View filing on SEC.gov →

End of results.